Literature DB >> 22569318

Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.

Luiz F Pinheiro, Carolina N França, Maria C Izar, Simone P Barbosa, Henrique T Bianco, Soraia H Kasmas, Gustavo D Mendes, Rui M Povoa, Francisco A H Fonseca.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569318     DOI: 10.1016/j.ijcard.2012.04.051

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  12 in total

1.  A Meta-Analysis of Circulating Microvesicles in Patients with Myocardial Infarction.

Authors:  Zhida Wang; Wang Cai; Shaolan Hu; Yufei Xia; Yao Wang; Qi Zhang; Liming Chen
Journal:  Arq Bras Cardiol       Date:  2017-07-10       Impact factor: 2.000

2.  Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy.

Authors:  L M Camargo; C N França; M C Izar; H T Bianco; L S Lins; S P Barbosa; L F Pinheiro; F A H Fonseca
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

Review 3.  Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy.

Authors:  Zhi-Yu Wang; Meng Chen; Ling-Ling Zhu; Lu-Shan Yu; Su Zeng; Mei-Xiang Xiang; Quan Zhou
Journal:  Ther Clin Risk Manag       Date:  2015-03-19       Impact factor: 2.423

Review 4.  Microparticles as potential biomarkers of cardiovascular disease.

Authors:  Carolina Nunes França; Maria Cristina de Oliveira Izar; Jônatas Bussador do Amaral; Daniela Melo Tegani; Francisco Antonio Helfenstein Fonseca
Journal:  Arq Bras Cardiol       Date:  2015-01-27       Impact factor: 2.000

5.  Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial.

Authors:  Francisco A H Fonseca; Maria Cristina Izar; Ieda M L Maugeri; Otavio Berwanger; Lucas P Damiani; Ibraim M Pinto; Gilberto Szarf; Carolina N França; Henrique T Bianco; Flavio T Moreira; Adriano Caixeta; Claudia M R Alves; Aline Soriano Lopes; Aline Klassen; Marina F M Tavares; Henrique A Fonseca; Antonio C C Carvalho
Journal:  Trials       Date:  2017-12-19       Impact factor: 2.279

6.  Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction Between Clopidogrel and Dasabuvir.

Authors:  M Shebley; W Fu; P Badri; Daj Bow; V Fischer
Journal:  Clin Pharmacol Ther       Date:  2017-06-03       Impact factor: 6.875

7.  Effects of Chronic Exercise on Endothelial Progenitor Cells and Microparticles in Professional Runners.

Authors:  Célia Regina de Oliveira Bittencourt; Maria Cristina de Oliveira Izar; Carolina Nunes França; Valdir Lauro Schwerz; Rui Manuel Dos Santos Póvoa; Francisco Antonio Helfenstein Fonseca
Journal:  Arq Bras Cardiol       Date:  2017-03       Impact factor: 2.000

8.  Circulating microparticles and central blood pressure according to antihypertensive strategy.

Authors:  Nayara D Massunaga; Carolina N França; Henrique T Bianco; Carlos E S Ferreira; Juliana T Kato; Rui M S Póvoa; Antonio M Figueiredo Neto; Maria Cristina O Izar; Francisco Antonio Helfenstein Fonseca
Journal:  Clinics (Sao Paulo)       Date:  2019-11-11       Impact factor: 2.365

9.  Adverse drug reactions in hospitalized Colombian children.

Authors:  Roxana de Las Salas; Daniela Díaz-Agudelo; Francisco Javier Burgos-Flórez; Claudia Vaca; Dolores Vanessa Serrano-Meriño
Journal:  Colomb Med (Cali)       Date:  2016-09-30

Review 10.  The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles.

Authors:  Justyna Rosińska; Maria Łukasik; Wojciech Kozubski
Journal:  Cardiovasc Drugs Ther       Date:  2017-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.